There are several things wrong with this.
“We don’t know they cause long-term harm.”
That is not true in any meaningful sense.
We know puberty blockers can cause harm. Even in their accepted use for central precocious puberty, there are recognised adverse effects and warnings. The FDA has added warnings for GnRH agonists, including risks such as pseudotumor cerebri, also called idiopathic intracranial hypertension. Lupron Depot-Ped’s own safety information refers to psychiatric events and seizures. So the idea that these are harmless “pause buttons” is simply false. (U.S. Food and Drug Administration)
There have also been legal actions, investigations and reported complaints around Lupron and alleged long-term harms in children, including women who were treated for early puberty and later reported serious health problems. That does not by itself prove every allegation, but it absolutely destroys the breezy claim that there is no long-term harm issue here. (STAT)
”The only concrete harm is bone density, and it recovers.”
No. That is far too simplistic.
Bone density is a serious issue in children because puberty is when a huge amount of adult bone strength is built. Even if some recovery happens after stopping, that claim depends on the child actually stopping blockers and going through normal puberty. In the gender pathway, many do not simply stop. They move on to cross-sex hormones. That is a totally different risk profile.
And bone density is not the only concern. Cass raised uncertainty around neurocognitive development, psychosexual development and other physical and mental-health outcomes. NHS England stopped routine commissioning because there was not enough evidence of safety or clinical effectiveness. (NHS England)
“They are used safely for precocious puberty.”
Central precocious puberty is a real, objective, verifiable medical condition. It means puberty has started abnormally early, classically before age 8 in girls and before age 9 in boys. In that situation, the child’s development is already medically abnormal, and the treatment aim is to restore puberty to more normal timing. (dfs.ny.gov)
That is completely different from giving the same drugs to an 11-year-old whose puberty is normal but who is distressed by it.
One is treating an abnormal early puberty. The other is stopping healthy puberty because of a psychological identity conflict. Those are not remotely the same ethical or medical situation.
”There is no reason they would be safe for one group but dangerous for another.”
Of course there is.
The risk-benefit calculation depends on the condition being treated, the aim of treatment, duration, age, baseline health, and what comes next.
A drug can be justified for a real endocrine disorder and unjustified for a child whose body is developing normally. Chemotherapy is justified for cancer. That does not make it acceptable for a healthy child who is distressed by their body.
”Cass did not recommend an outright ban.”
Cass did not give puberty blockers a clean bill of health. Quite the opposite.
The whole point of the Cass Review was that the evidence base was weak, the “time to think” claim was not properly supported, and the risks and benefits were not established. NHS England then stopped routine prescribing for gender incongruence/gender dysphoria in children. (NHS England)
That is not a minor caveat. It is a huge red flag.
”This is just between families and doctors.”
No. These are children.
When an intervention affects puberty, fertility, sexual development, bone development, brain development and future adult sexual function, it is absolutely a matter of safeguarding and public concern.
Parents and doctors do not have unlimited authority to medicalise a child’s healthy body, especially when the evidence of benefit is weak and the possible harms are profound.
”This is anti-trans.”
No. This is pro-child.
Adults can make adult decisions. Children cannot meaningfully consent to losing normal puberty, future fertility, normal sexual function or a non-medicalised adult life.
The real issue is still this: what is the positive outcome?
If the good outcome is the child no longer having gender incongruence, then blockers do not do that. Cross-sex hormones do not do that. Surgery does not do that. None of it changes sex.
The best outcome is a child being helped to live peacefully in their own body. That requires careful, whole-child psychological support, not drugs that stop normal puberty and place them on a pathway to lifelong medicalisation.